Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

NCT07245407 ·Status: RECRUITING

Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)

NCT05273359 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02155660 ·Status: COMPLETED ·Phase: PHASE3

Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA)

NCT07530263 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis

NCT05189613 ·Status: UNKNOWN ·Phase: NA

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

NCT06016088 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

NCT05010577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease

NCT05494957 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

NCT04773678 ·Status: COMPLETED ·Phase: PHASE2

Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.

NCT01983657 ·Status: UNKNOWN ·Phase: PHASE2

An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)

NCT00787917 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis

NCT01255592 ·Status: COMPLETED ·Phase: PHASE2

Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF

NCT03153800 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Clinical Practice of AECOPD Management in China

NCT02051166 ·Status: COMPLETED

A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis

NCT00005110 ·Status: SUSPENDED ·Phase: NA

Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

NCT02722304 ·Status: TERMINATED ·Phase: PHASE3

A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355

NCT01043276 ·Status: COMPLETED ·Phase: PHASE1

Bevacizumab in Patients With Severe Covid-19

NCT04305106 ·Status: UNKNOWN ·Phase: PHASE3

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD

NCT05507242 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

NCT05667662 ·Status: TERMINATED ·Phase: PHASE2

Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)

NCT04442269 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection

NCT05616221 ·Status: COMPLETED ·Phase: PHASE2

Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis

NCT06775340 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

NCT00070590 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis

NCT00518310 ·Status: UNKNOWN ·Phase: NA